• Moolec flagged a material deterioration in liquidity, raising going-concern risk as prior shareholder and related-party financial support ended.
• A winding-up petition filed by Linklaters over a disputed alleged debt has hindered efforts to secure replacement financing.
• Linklaters billed about USD 6.1 million from January 2023 through June 2025; about USD 3.8 million was paid; about USD 2.3 million is claimed unpaid.
• Current management said it did not approve or ratify the disputed fee arrangements.
• The company plans to pursue claims against Linklaters for losses and costs tied to the petition.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Moolec Science SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-096759), on September 02, 2026, and is solely responsible for the information contained therein.